Log In
Print
BCIQ
Print
Print this Print this
 

Comtan, entacapone

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionCatechol-O-methyl-transferase (COMT) inhibitor that inhibits breakdown of levodopa
Molecular Target Catechol-O-methyl-transferase (COMT)
Mechanism of ActionCatechol-O-methyl-transferase (COMT) inhibitor
Latest Stage of DevelopmentMarketed
IndicationParkinson's disease (PD)
Partner

Orion Corp.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today